A structure-based approach to designing synthetic CD8α peptides that can inhibit cytotoxic T-lymphocyte responses

Nature Medicine

Volumn 4, Issue 3, 1998, Pages 309-314

  Choksi, Swati ^a   Jameson, Bradford A ^a,b   Korngold, Robert ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; SYNTHETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE ACTIVATION;

ANIMALS; ANTIGENS, CD8; CYTOTOXICITY, IMMUNOLOGIC; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; GRAFT REJECTION; GRAFT SURVIVAL; H-2 ANTIGENS; MICE; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; SKIN TRANSPLANTATION; T-LYMPHOCYTES, CYTOTOXIC; TRANSPLANTATION, HOMOLOGOUS;

ANIMALIA;

EID: 0031889939     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0398-309     Document Type: Article

References (35)

1. Doherty, P.C. T cells and viral infections. Br. Med. Bull. 41, 7-14 (1985).
2. Tanaka, K., Yoshioka, T., Bieberich, C. & Jay, G. Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu. Rev. Immunol. 6, 359-380 (1988).
3. Mason, D.W. & Morris, P.J. Effector mechanisms in allograft rejection. Annu. Rev. Immunol. 4, 119-145 (1986).
4. Zinkernagel, R.M. & Doherty, P.C. H-2 compatibility requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus: Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D. J. Exp. Med. 141, 1427-1436 (1975).
5. Miceli, M.C. & Parnes, J.R. Role of CD4 and CD8 in T cell activation and differentiation. Adv. Immunol. 53, 59-122 (1993).
6. Norment, A.M., Salter, R.D., Parham, P., Engelhard, V.H. & Littman, D.R. Cell-cell adhesion mediated by CD8 and MHC class I molecules. Nature 336, 79-81 (1988).
7. Salter, R.D., et al. A binding site for the T-cell co-receptor CD8 on the alpha 3 domain of HLA-A2. Nature 345, 41-46 (1990).
8. lck. Cell 55, 301-308 (1988).
9. Zamoyska, R., et al. Inability of CD8 alpha polypeptides to associate with p56lck correlates with impaired function in vitro and lack of expression in vivo. Nature 342, 278-281 (1989).
10. Parnes, J.R. Molecular biology and function of CD4 and CD8. Adv. Immunol. 44, 265-305 (1989).
11. Hunkapiller, T. & Hood, L. Diversity of the immunoglobulin gene superfamily. Adv. Immunol. 44, 1-63 (1989).
12. Williams, A.F. & Barclay, A.N. The immunoglobulin superfamily-domains for cell surface recognition. Ann. Rev. Immunol. 6, 381-405 (1988).
13. Sukhatme, V.P., Sizer, K.C., Vollmer, A.C., Hunkapiller, T. & Parnes, J.R. The T cell differentiation antigen Leu-2/T8 is homologous to immunoglobulin and T cell receptor variable regions. Cell 40, 591-597 (1985).
14. Nakauchi, H., et al. Molecular cloning of Lyt-2, a membrane glycoprotein marking a subset of mouse T lymphocytes: molecular homology to its human counterpart, Leu-2/T8, and to immunoglobulin variable regions. Proc. Natl. Acad. Sci. USA 82, 5126-5130 (1985).
15. Leahy, D.J., Axel, R. & Hendrickson, W.A. Crystal structure of a soluble form of the human T cell co-receptor CD8 at 2.6 A resolution. Cell 68, 1145-1162 (1992).
16. Jameson, B.A., McDonnell, J.M., Marini, J.C. & Korngold, R. A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368, 744-746 (1994).
17. Jameson, B.A. Modelling in peptide design. Nature 341, 465-466 (1989).
18. Sanders, S.K., Fox, R.O. & Kavathas, P. Mutations in CD8 that affect interactions with HLA class I and monoclonal anti-CD8 antibodies. J. Exp. Med. 174, 371-379 (1991).
19. Franco, M.D., et al. Regions of the CD8 molecule involved in the regulation of CD2-mediated activation. Cell. Immunol. 157, 341-352 (1994).
20. Ciblin, P.A., Leahy, D.J., Mennone, J. & Kavathas, P.B. The role of charge and multiple faces of the CD8 alpha/alpha homodimer in binding to major histocompatibility complex class I molecules: Support for a bivalent model. Proc. Natl. Acad. Sci. USA 91, 1716-1720 (1994).
21. Clayberger, C., Lyu, S.C., DeKruyff, R., Parham, P. & Krensky, A.M. Peptides corresponding to the CD8 and CD4 binding domains of HLA molecules block T lymphocyte immune responses in vitro. J. Immunol. 153, 946-951 (1994).
22. Emmrich, F., Strittmatter, U. & Eichmann, K. Synergism in the activation of human CD8 T cells by cross-linking the T-cell receptor complex with the CD8 differentiation antigen. Proc Natl. Acad. Sci. USA 83, 8298-8302 (1986).
23. Gao, G.F., et al. Crystal structure of the complex between human CD8αα and HLA-A2. Nature 387, 630-634 (1997).
24. + T lymphocytes. Eur. J. Immunol. 23, 2834-2840 (1994).
25. Eichmann, K., et al. Affinity enhancement and transmembrane signaling are associated with distinct epitopes on the CD8 alpha beta heterodimer. J. Immunol. 147, 2075-2081 (1991).
26. Connolly, J.M., Hansen, T.H., Ingold, A.L. & Potter, T.A. Recognition by CD8 on cytotoxic T lymphocytes is ablated by several substitutions in the class I alpha 3 domain: CD8 and the T-cell receptor recognize the same class I molecule. Proc. Natl. Acad. Sci. USA 87, 2137-2141 (1990).
27. Mescher, M.F. Molecular interactions in the activation of effector and precursor cytotoxic T lymphocytes. Immunol. Rev. 146, 177-210 (1995).
28. Cai, Z. & Sprent, J. Resting and activated T cells display different requirements for CD8 molecules. J. Exp. Med. 179, 2005-2015 (1994).
29. O'Rourke, A.M. & Mescher, M.F. Signals for activation of CD8-dependent adhesion and costimulation in CTLs. J. Immunol. 152, 4358-4367 (1994).
30. Zamoyska, R., Vollmer, A.C., Sizer, K.C., Liaw, C.W. & Parnes, J.R. Two Lyt-2 polypeptides arise from a single gene by alternative splicing patterns of mRNA. Cell 43, 153-163 (1985).
31. Karplus, M. & Petsko, G.A. Molecular dynamics simulations in biology. Nature 347, 631-639 (1989).
32. McDonnell, J.M., Blank, K.J., Rao, P.E. & Jameson, B.A. Direct involvement of the CDR3-like domain of CD4 in T helper cell activation. J. Immunol. 149, 1626-1630 (1992).
33. Bailey, D.W. & Usama, B. A rapid method of grafting skin on tails of mice. Transplant. Bull. 7, 424-425 (1960).
34. Sprent, J., Schaefer, M., Lo, D. & Korngold, R. Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J. Exp. Med. 163, 998-1011 (1986).
35. Kraulis, P.J. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24, 946-950 (1991).